JW Pharmaceutical Corp (001067) — Net Asset Quality Index
JW Pharmaceutical Corp (001067) has a Net Asset Quality Index of 57.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩611.56 Billion minus total liabilities of ₩257.46 Billion yields net assets of ₩354.10 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check JW Pharmaceutical Corp asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
JW Pharmaceutical Corp Net Asset Quality Index Over Time (2014–2024)
This chart shows how JW Pharmaceutical Corp's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 57.9%, representing net assets of ₩354.10 Billion against total assets of ₩611.56 Billion KRW. See 001067 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for JW Pharmaceutical Corp (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for JW Pharmaceutical Corp from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see JW Pharmaceutical Corp (001067) total market value.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 54.5% | ₩329.49 Billion | ₩604.60 Billion | ₩275.11 Billion | ▲ +13.3 pp |
| 2023 | 41.2% | ₩265.44 Billion | ₩645.04 Billion | ₩379.60 Billion | ▲ +5.2 pp |
| 2022 | 36.0% | ₩225.76 Billion | ₩627.97 Billion | ₩402.21 Billion | ▲ +6.2 pp |
| 2021 | 29.8% | ₩188.54 Billion | ₩633.05 Billion | ₩444.51 Billion | ▼ -8.0 pp |
| 2020 | 37.8% | ₩207.47 Billion | ₩549.09 Billion | ₩341.62 Billion | ▼ -2.4 pp |
| 2019 | 40.1% | ₩230.09 Billion | ₩573.21 Billion | ₩343.12 Billion | ▼ -3.7 pp |
| 2018 | 43.8% | ₩260.11 Billion | ₩593.79 Billion | ₩333.68 Billion | ▲ +0.9 pp |
| 2017 | 42.9% | ₩270.78 Billion | ₩630.87 Billion | ₩360.10 Billion | ▲ +0.5 pp |
| 2016 | 42.4% | ₩276.31 Billion | ₩651.08 Billion | ₩374.76 Billion | ▲ +5.7 pp |
| 2015 | 36.7% | ₩225.41 Billion | ₩613.48 Billion | ₩388.07 Billion | ▼ -0.6 pp |
| 2014 | 37.3% | ₩220.02 Billion | ₩589.24 Billion | ₩369.22 Billion | — |